Duron, Sherlita T.

HRN: 22-11-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/29/2022
11/04/2022
IV
600mg
Q8
Septicemia, HAP
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: